Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies
Open Access
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 21 (12) , 2160-2166
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P01 CA23766)
This publication has 67 references indexed in Scilit:
- Immune Reconstitution after Double Umbilical Cord Blood Stem Cell Transplantation: Comparison with Unrelated Peripheral Blood Stem Cell TransplantationTransplantation and Cellular Therapy, 2012
- Serious Infection Risk and Immune Recovery after Double-Unit Cord Blood Transplantation Without Antithymocyte GlobulinTransplantation and Cellular Therapy, 2011
- Reduced Late Mortality Risk Contributes to Similar Survival after Double-Unit Cord Blood Transplantation Compared with Related and Unrelated Donor Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2011
- How I treat: the selection and acquisition of unrelated cord blood graftsBlood, 2011
- Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord bloodBlood, 2010
- Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisThe Lancet Oncology, 2010
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Response to Pneumococcal (PNCRM7) and Haemophilus Influenzae Conjugate Vaccines (HIB) in Pediatric and Adult Recipients of an Allogeneic Hematopoietic Cell Transplantation (alloHCT)Transplantation and Cellular Therapy, 2008
- Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewingBlood, 2007
- Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplantsBlood, 2006